Inactive Instrument
BiVictriX Therapeutics plc Share Price
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 01/01/2016 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 03/10/2023 |
Alison Halsall
SEC | Corporate Secretary | - | 13/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 01/01/2016 |
Susan Lowther
BRD | Director/Board Member | 67 | 22/09/2021 |
William Paris
BRD | Director/Board Member | 75 | 22/09/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/24 | Buy | Director | 20,000 | 0.0242% | ||
| 02/09/24 | Sell | Director | 20,000 | 0.0242% | ||
| 13/08/24 | Free | Executive/Senior Manager | 3,20,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +17.65% | +33.33% | - | - | 1.05Cr | ||
| -2.49% | -3.76% | +53.38% | +62.10% | 6.37TCr | ||
| -0.63% | -2.91% | +6.55% | +89.34% | 5.86TCr | ||
| -2.37% | -2.22% | +21.77% | +84.58% | 5.42TCr | ||
| -2.19% | -6.15% | +12.43% | +111.40% | 4.47TCr | ||
| -1.89% | -7.28% | +9.30% | +18.50% | 4.05TCr | ||
| -0.93% | -0.47% | +19.34% | +41.83% | 3.63TCr | ||
| +1.11% | -6.44% | +127.46% | +675.37% | 3.49TCr | ||
| -0.80% | +0.61% | +76.27% | +61.80% | 3.23TCr | ||
| -2.17% | +16.65% | -28.89% | +479.93% | 3.1TCr | ||
| Average | +0.53% | -1.22% | +33.07% | +180.54% | 4TCr | |
| Weighted average by Cap. | -1.48% | -1.85% | +31.83% | +155.14% |
Employees
-
















